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Objectives We investigated the secular trend in white blood cell (WBC) count and the relationship between WBC count and
mortality between 1958 and 2002.
Background The WBC count is a clinical marker of inflammation and a strong predictor of mortality. Limited data exist on the
WBC count secular trend and the relationship between WBC and mortality.
Methods One thousand eighty-three women and 1,720 men were evaluated longitudinally in the Baltimore Longitudinal
Study of Aging. Blood samples and medical information were collected at the study entry and every 2 years dur-
ing follow-up visits. The WBC count and all-cause, cardiovascular, and cancer mortality were assessed.
Results A downward trend in WBC count was observed from 1958 to 2002. The secular downward trend was indepen-
dent of age, gender, race, smoking, body mass index, and physical activity. The WBC count was nonlinearly asso-
ciated with all-cause mortality and almost linearly associated with cardiovascular mortality. Participants with
baseline WBC 3,500 cells/mm3 and WBC 6,000 cells/mm3 had higher mortality than those with 3,500 to
6,000 WBC/mm3. Within each WBC group, age-adjusted mortality rates declined in successive cohorts from the
1960s to the 1990s. Participants who died had higher WBC than those who survived, and the difference was
statistically significant within 5 years before death.
Conclusions Our study provides evidence for a secular downward trend in WBC count over the period from 1958 to 2002.
Higher WBC counts are associated with higher mortality in successive cohorts. We found no evidence that the decline
of age-specific mortality rates that occurred from 1960 to 2000 was attributable to a secular downward trend
in WBC. (J Am Coll Cardiol 2007;49:1841–50) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.01.076m
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chite blood cell (WBC) count is a marker of systemic
nflammation, and elevated WBC count is associated with
ll-cause (1) as well as cancer (2), cerebrovascular (3), and
ardiovascular (4) mortality. The WBC count is an inde-
endent risk factor for cardiovascular and cerebrovascular
vents (3,5) and a negative prognostic factor in congenital
eart disease patients (6). Accordingly, WBC count is
onsidered a biomarker of inflammatory processes that
ctively contribute to vascular injury and atherosclerosis
7,8). Whether elevated WBC count directly contributes to
ardiovascular disease and mortality (9) or is merely a
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ntramural Research Program of the National Institute on Aging, National Institutes
f Health.B
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007, accepted January 13, 2007.arker of negative cardiovascular risk profile remains con-
roversial (10,11).
Over the last century, the percentage of persons who
moke declined, whereas the percentage of obese and
edentary individuals increased substantially (12,13).
hether the longitudinal trends in these risk factors ac-
ount for changes in WBC count and potentially for the
ssociation between WBC count and mortality has not been
nvestigated. Limited data exist on the longitudinal trend of
BC and the relationship between WBC and mortality
ver the second half of the 20th century. With the data from
he BLSA (Baltimore Longitudinal Study of Aging) trial
athered from 1958 to 2002, we studied the longitudinal
rend in WBC count and the relationship between WBC
nd mortality.
ethods
tudy sample. The BLSA trial is a cohort of volunteers
ontinually recruited since 1958, primarily from the
altimore-Washington, DC, area. Participants healthy at
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White Blood Cell Count and Mortality May 8, 2007:1841–50study entry were consecutively
enrolled in the study. From 1958
to 1978 the cohort included ex-
clusively men; women were en-
rolled after 1978. A general de-
scription of the BLSA trial has
been previously reported (14).
In this analysis, we considered
2,803 participants (1,083 women
and 1,720 men) enrolled from
958 to 2002. Participants had a median of 4 evaluations
range 1 to 28). Men had a median of 6 visits (range 1 to 28)
ver 22  13.6 years, and women had a median of 3 visits
range 1 to 14) over 13  7.9 years: 272 men and 294
omen had a single evaluation.
Participants were evaluated every 2 years at the Geron-
ology Research Center in Baltimore, Maryland. Follow-up
isits lasted 2 to 3 days and included medical evaluations
nd physiological and cognitive tests performed by a phy-
ician, nurse practitioner, or physician assistant. Fasting
lood samples were collected in the morning and analyzed
y the clinical laboratory of the Johns Hopkins Bayview
edical Center.
BC count. Total WBC count (cells/mm3) was per-
ormed with standard automated clinical methodologies.
valuating WBC trajectories over time in specific individual
nd in the entire sample, we found no evidence for sudden
aseline Characteristics of the Study Participants According to the
Table 1 Baseline Characteristics of the Study Participants Acc
Women
Decedents
(n  169)
Survivors
(n  914)
Age at evaluation (yrs) 72.4 11.0 49.5 16.2
Length of follow-up (yrs) 12.0 6.0 13.0 7.9
WBC at evaluation (cells/mm3) 6,589 1,624 6,077 1,657
Neutrophils (cells/mm3) 4,118 1,308 3,785 1,500
Lymphocytes (cells/mm3) 1,857 653 1,853 742
BMI (kg/m2) 24.8 4.6 24.6 4.5
Weight (kg) 62.6 10.8 62.4 12.2
Height (cm) 160.8 5.6 163.8 6.8
Physical activity (METs/day)
Moderate intensity 233 230 280 236
High intensity 80 193 125 188
Total 2,121 379 2,330 419
Smoking status (%)
Never 55.0 56.6
Former 29.6 30.4
Current 15.4 13.0
Blood pressure (mm Hg)
Systolic 139.3 24.0 120.9 18.8
Diastolic 79.6 11.4 76.0 10.2
Lipids (mg/dl)
Triglycerides 105 81 79 47
Cholesterol 235 43.1 204 40
Diabetes (%) 3.5 0.3
Abbreviations
and Acronyms
BMI  body mass index
CI  confidence interval
HR  hazard ratio
MET  metabolic unit
WBC  white blood cellata are presented as mean  SD, if not otherwise indicated. p values are from t test or chi-square test
BMI  body mass index; MET  metabolic unit; WBC  white blood cell.hange in WBC count at the times when methods for the
ssessment of WBC count were changed.
Participants were grouped according to the following cut
oints: 3,500, 6,000, and 10,000 cells/mm3. Two of these
alues delimit the WBC count normal range (3,500 to
0,000 cells/mm3), whereas 6,000 is the WBC count
hreshold above which mortality was higher than the aver-
ge population mortality. Differential blood counts were
btained starting in 1968 and are available for only part of
he database. Percentages of neutrophils and lymphocytes
ere determined by microscopic examination of Giemsa-
tained peripheral blood smear. The absolute neutrophil and
ymphocyte counts were calculated applying percentage to
otal WBC count.
ortality. Participants’ vital status was determined by
elephone follow-up, correspondence, and searches of the
ational Death Index. Cause of death was determined by a
onsensus of 3 physicians who reviewed death certificates,
edical records, correspondences, and other available ma-
erial and adjudicated as “cardiovascular,” “cancer,” or
other.”
ovariates. Body mass index (BMI) was calculated as
eight in kilograms divided by the square of height in
eters. Participants were categorized as smokers, former
mokers, or never smokers at each visit, on the basis of
elf-report. Leisure time physical activity was assessed by
elf-report of the amount of time spent performing 97
l Status at the End of the Follow-Up
g to the Vital Status at the End of the Follow-Up
Men
p Value
Decedents
(n  775)
Survivors
(n  945) p Value
0.0001 62.2 13.9 44.2 16.9 0.0001
0.0001 17.7 10.4 22.0 13.6 0.0001
0.0013 7,420 1,955 6,379 2,231 0.0001
0.19 4,747 1,749 3,644 1,296 0.0001
0.09 1,809 737 1,867 734 0.0057
0.70 25.2 3.0 25.5 3.5 0.40
0.87 77.3 11.0 80.4 12.3 0.85
0.84 175.2 6.5 177.4 7.1 0.57
0.48 233 229 343 293 0.0560
0.31 81 141 185 234 0.01
0.078 1,995 448 2,324 494 0.0650
0.11 33.6 42.4 0.38
38.5 34.4
28.0 23.2
0.0214 136.5 20.8 124.5 16.1 0.0039
0.14 82.3 11.5 79.4 10.2 0.0866
0.22 120 73 106 73 0.15
0.50 231 42.6 206 38 0.29
0.019 3.8 1.4 0.0230Vita
ordin.
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May 8, 2007:1841–50 White Blood Cell Count and Mortalityctivities on the basis of a typical day, averaged over the
rior 2 years (15). Each activity was assigned a value for
etabolic units (METs) (METs/min or metabolic equiva-
ents of resting oxygen consumption/min) with the coding
ystem described by Ainsworth (16) and Jetté (17) and
ategorized according to MET intensity, as low intensity
4 METs), moderate intensity (4.1 to 5.9 METs), and
igh intensity (6 METs). Leisure time physical activity was
nally expressed in average total METs/day. Diabetes
ellitus was defined on the basis of the 1997 American
iabetes Association criteria (18). Plasma triglycerides and
otal cholesterol concentrations were determined with an
nzymatic method (ABA-200 ATC Biochromatic Ana-
yzer, Abbott Laboratories, Irving, Texas). Blood pressure
as measured at the brachial artery with the participants
itting and with a sphygmomanometer which was calibrated
t regular intervals with a mercury standard (19).
tatistical analysis of the data. Differences in baseline
haracteristics between survivors and decedents were tested
ith Student t or chi-square tests. In analyses limited to
elected decades, WBC counts, covariate, and outcome
alues were derived from BLSA trial visits that occurred
uring that decade. Crude all-cause, cardiovascular, and
ancer mortality rates were expressed as the number of
vents/1,000 person-years according to WBC count groups.
he hypothesis that WBC count changed over time across
aseline Characteristics of the Study Participants According to WB
Table 2 Baseline Characteristics of the Study Participants Acc
<3,500 3,501–
Number of subjects, n (% female) 49 (55.1) 1,192
Race (% Caucasian) 33.3 79
Age (yrs at baseline) 56.9 15.7 51.4
Length follow-up (yrs) 7.0 6.6 15.7
WBC (cells/mm3) 3,100 348 5,106
Neutrophils (cells/mm3) 1,510 0,599 3,010
Lymphocytes (cells/mm3) 1,224 499 1,579
Smoking (%)
Never 67.3 52
Former 32.7 36
Current 0.0 11
BMI (kg/m2) 25.4 4.1 25.0
Weight (kg) 74.2 14.1 72.8
Height (cm) 170.4 9.8 171.4
Physical activity (METs/day)
Moderate intensity 305 228 290
High intensity 67 123 145
Total 2,210 515 2,302
Blood pressure (mm Hg)
Systolic 128.8 19.4 125.6
Diastolic 80.4 14.0 78.7
Lipids (mg/dl)
Triglycerides 73.5 38.2 88.2
Cholesterol 196 39 208.7
Diabetes (%) 0.0 1ata are presented as mean  SD, otherwise as indicated. p values from analysis of variance or chi-squ
Abbreviations as in Table 1.epeated measurements as an age-independent secular trend
as tested with mixed effects models on the basis of
on-linear mixed effects procedure in S-PLUS 6.2 (Insight-
ul Inc., Seattle, Washington) (20).
Proportional hazards regression models were used to
etermine the contribution of WBC count to mortality,
ith the survival functions developed by Therneau and
rambsch (21). The Martingale residuals from the propor-
ional hazards regression models were plotted versus WBC
ount. The Martingale residuals represent the “excess mor-
ality” that reflects the discrepancy between observed hazard
nd expected hazard of mortality (21). Exploration of the
artingale residuals further supported the WBC classifica-
ion into the 4 groups (3,500; 3,501 to 6,000; 6,001 to
0,000; 10,000) used in this analysis.
The effect of baseline WBC count on mortality was
xamined by Kaplan-Meier estimates and tested by propor-
ional hazard analysis, with the classification in 4 WBC
ount groups described previously. In additional analyses,
e used longitudinal time-dependent survival models where
he subject’s WBC count and covariates were allowed to
ary over time. Time-dependent covariates in the longitu-
inal analyses used the Anderson-Gill formulation as a
ounting process (22). For each subject, time was divided
nto intervals between evaluations, and the covariates were
ased on the evaluation at the start of the interval. Thus, the
unt Groupings
g to WBC Count Groupings
WBC Count (Groups)
6,001–10,000 >10,000 p Value
1,433 (32.8) 129 (18.6) 0.0001
90.7 94.4 0.10
53.5 17.8 52.8 17.3 0.0001
18.7 11.6 19.7 12.2 0.0002
7,447 1,020 11,711 3,682 0.0001
4,585 1,087 8,000 1,725 0.0001
2,044 1,064 4,479 1,064 0.0001
0.0001
40.6 21.1
33.2 22.7
26.2 56.2
25.2 3.7 24.8 4.1 0.06
74.2 13.4 74.8 14.5 0.35
171.4 9.4 173.4 9.0 0.03
290 275 239 192 0.443
124 196 112 175 0.218
2,214 483 2,107 372 0.078
128.9 19.9 133.0 21.0 0.164
79.6 11.1 81.5 11.0 0.732
108.6 75.7 119 70.2 0.0001
216.4 42 211 42 0.421
2.3 3.8 0.98C Co
ordin
6,000
(47.1)
.6
18.0
10.8
631
0,696
0,508
.7
.1
.2
3.9
14.1
9.4
243
211
447
20.3
10.6
55
41.8
.2are test.
i
l
v
p
M
g
s
W
u
s
t
r
c
t
w
s
a
m
r
(
c
s
R
D
p
t
W
y
1
w
1844 Ruggiero et al. JACC Vol. 49, No. 18, 2007
White Blood Cell Count and Mortality May 8, 2007:1841–50ndependent variables can increase or decrease over time. This
ongitudinal time-dependent survival functions have been de-
eloped in S-PLUS 6.2 by Therneu and Brambsch (21).
Proportionality was examined with both Kaplan-Meier
lots and scaled Schoenfeld residuals by time plots. Kaplan-
eier plots examined the survival function in each WBC
roup according to the baseline evaluations. Survival plots
eemed to be proportional, with exception of group with
BC count 3,500. Given a covariate, Schoenfeld resid-
als are the covariate-value for each person who died at a
pecific time minus the expected value of the covariate for
he risk set at that specific time. Plotting Schoenfeld
esidual against the log transformation of time, with the
ox.zph procedure in S-PLUS 6.2, the proportionality of
he hazard was confirmed in all WBC groups.
To test whether the effect of WBC count on mortality
as due to a relative acute or rapidly progressing illness,
urvival models were also estimated in subjects who survived
t least 3 or 5 years after their initial evaluation. These
odels had similar findings to the full models and are not
eported.
All analyses were performed with S-PLUS version 6.2
Figure 1 Longitudinal Changes in WBC Count by Years
of Initial Evaluation, Separately in Men and Women
The upward trend of white blood cell (WBC) count in the oldest cohorts can be
explained by participants enrolled in the first 2 enrollment periods, who devel-
oped an increase in WBC count in their very old age. Numbers in the table are
for participants enrolled in different time periods and, of these, the number
who were still alive at the beginning of each decade.Insightful Inc.). A 2-tailed p value 0.05 and 95%onfidence interval (CI) were used to indicate statistical
ignificance.
esults
escription of the sample. Characteristics of the partici-
ants are reported in Table 1 according to the vital status at
he end of the follow-up and in Table 2 according to the
BC groups. There were 944 deaths over 48,347 person-
ears of follow-up: the unadjusted mortality rate was 22.5/
,000 person-years in men and 12.7/1,000 person-years in
omen. Compared with survivors, those who died were
Figure 2 Relationship Between Excess Mortality and
WBC Count in the Entire BLSA Trial Sample
The absolute difference between the observed mortality hazard and the
expected mortality hazard over time is expressed as excess mortality and plot-
ted against white blood cell (WBC) count for the entire sample. The dashed
lines represent the 95% confidence intervals.
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May 8, 2007:1841–50 White Blood Cell Count and Mortalityore likely to be smokers, were less physically active, and
ad significantly worse cardiovascular risk profile. Indepen-
ent of age and date, both at baseline and in subsequent
ollow-up visits, decedents had higher WBC count than
urvivors (Table 1). Women had significantly lower WBC
ount than men, but WBC count was not significantly
orrelated with age in either gender.
BC count secular trend. A secular downward trend of
BC count was observed in both genders, (linear, qua-
ratic, and cubic effects of date, p  0.0001) in the period
rom 1958 to 2002 (Figs. 1A and 1B). Independent of age,
he WBC rate of change in men was 114 cells/year in
965 and became 48 cells/year in 1995 and in women was
cells/year in 1985 and became48 cells/year in 1995. The
ownward trend in WBC count observed in men was
ndependent of the age of the participants at the study entry
n each decade from the 1960s to the 1990s. An exception
as the irregular WBC count time trends found in partic-
pants older than 80 years over all the decades (data not
hown) and the higher WBC count observed in the partic-
pants enrolled at age 40 to 59.9 years in the decade 1990 to
000. Results were similar for women, limited to the 2
ecades of enrollment (data not shown). In the period from
958 to 2002, former and current smokers had always
igher WBC count than never smokers and participants
ith higher BMI considered as time-dependent covariates
ad higher WBC count. However, WBC secular downward
rend was independent of smoking and/or BMI in the entire
eriod (data not shown). On the contrary, being physically
ctive was associated with lower WBC count. An increase in
hysical activities of 100 METs/min/day was associated
ith a decrease of 18 WBC/mm3. However, the slight
hanges of physical activity in the BLSA participants over
ime did not significantly impact the WBC count secular
ownward trend.
BC count and mortality. The relationship between
BC count and mortality was nonlinear, with a nonsignif-
cant upward mortality trend for WBC 3,500/mm3 and a
ignificant linear increase in mortality for WBC 3,500/
m3 (Fig. 2A). Cardiovascular mortality increased linearly
ith higher WBC count (Fig. 2B), whereas there was a little
Mortality Rate and Hazard Ratio in WBC Count
Table 3 Mortality Rate and Hazard Ratio in
<3,500
Person-years of follow-up (n) 345
Deaths (n) 5
Rate/1,000 person-yrs 14.5
Hazard ratio (95% CI)* 1.40 (0.58–3.41)
Adjusted hazard ratio (95% CI)† 1.53 (0.63–3.72)
Adjusted hazard ratio (95% CI)‡ —
*From Cox proportional hazard model; †from Cox proportional hazard
proportional hazard model with adjustments for age, gender, race, BM
cholesterol, triglycerides, and diabetes status.
CI  confidence interval; Ref  reference group; other abbreviationffect of WBC count on cancer mortality (Fig. 2C). Becausef the nonlinear relationship between WBC count and
ll-cause mortality, 4 WBC groups were identified on the
asis of the values that identify the WBC normal range in
ur laboratory (3,500 cells/mm3 and 10,000 cells/mm3) and
he visual identification of the value of WBC associated
ith increased mortality (6,000 cells/mm3) on functional
orm of the WBC mortality curve (Fig. 2, Table 2).
Figure 3 Kaplan-Meier Survival Curves and Proportional
Hazard Survival Plots According to WBC Count Groups
(A) Kaplan-Meier curves. (B) Proportional hazard survival plots were evaluated
at mean values of the explanatory variables. In participants with white blood
cell (WBC) count 3,500/mm3, the predicted survival was extrapolated up to
20 years of follow-up, because of the absence of events after 20 years.
s
Count Groups
WBC Count (Groups)
01–6,000 6,001–10,000 >10,000
8,726 26,730 2,547
256 606 77
13.7 22.7 30.2
1 (Ref) 1.54 (1.33–1.78) 1.99 (1.54–2.57)
1 (Ref) 1.24 (1.06–1.43) 1.76 (1.35–2.29)
1 (Ref) 1.28 (1.01–1.63) 1.62 (0.92–2.85)
with adjustments for age, gender, race, BMI, and smoking; ‡from Cox
ing, physical activity, systolic blood pressure, diastolic blood pressure,
Table 1.Group
WBC
3,5
1
model
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White Blood Cell Count and Mortality May 8, 2007:1841–50The lowest crude mortality rate was found among par-
icipants with WBC 3,501 to 6,000 (13.7/1,000 person-
ears). Participants with WBC count below and above the
ange 3,501 to 6,000 experienced increased mortality. The
ighest mortality (30.2/1,000 person-years) was observed in
articipants with WBC 10,000 (Table 3, Fig. 3A). Com-
ared with the WBC group with lowest crude mortality,
articipants with 6,001 to 10,000 WBC and those with
BC 10,000 had an unadjusted hazard ratio (HR) for
ortality of 1.54 (95% CI 1.33 to 1.78) and 1.99 (95% CI
.54 to 2.57), respectively (Table 3). After adjustment for
onfounders, the mortality HR remained significantly
igher in participants with WBC 6,001 to 10,000/mm3
HR 1.28, 95% CI 1.01 to 1.63), and in those with WBC
10,000 (HR 1.62, 95% CI 0.92 to 2.85) compared with
he reference group. The small number of participants did
ot allow any significant conclusion in term of mortality risk
ssociated with WBC3,500, although the partial adjusted
Rs tended to remain higher compared with the reference
roup (Table 3, Fig. 3B).
A further analytical model that allows participants to shift
etween WBC count groups over time confirmed the same
ndings. Participants within WBC 6,000 to 10,000, who
heoretically have “normal” WBC count, had 30% to 40%
igher risk of mortality compared with those with WBC
,501 to 6,000. Participants with WBC 3,500 had 3-fold
Mortality Hazard Ratio Comparing WBC CountGr ups From the Longitudinal Time-Depende M
Table 4 Mortality Hazard Ratio Comparing WGroups From the Longitudinal Time-
Model 1
WBC (cells/mm3)
3,500 2.98 (1.66–5.32) 2
3,501–6,000 1.0
6,001–10,000 1.32 (1.15–1.51) 1
10,000 2.00 (1.58–2.53) 2
Age (yrs) 1.10 (1.09–1.10) 1
Date (dd/mm/yy) 0.95 (0.94–0.96) 0
Gender (female) 1.10 (0.90–1.35) 1
Race
Caucasian (reference) 1.0
Afro-American 0.93 (0.59–1.47) 0
Other 0.42 (0.15–1.20) 0
BMI (kg/m2) 0
Physical activity (METs/day)
Smoking
Never
Former 1
Current 1
Blood pressure (mm Hg)
Systolic
Diastolic
Cholesterol (mg/dl)
Triglycerides (mg/dl)
Diabetes
Neutrophils (cells/mm3)
Abbreviations as in Table 1.igher mortality (HR 3.33, 95% CI 1.38 to 8.05), and those oith WBC 10,000 had 2-fold higher mortality (HR 2.12,
5% CI 1.45 to 3.08) compared with subjects with WBC
,501 to 6,000. These results remained statistically signifi-
ant after multiple adjustments (Table 4, Models 1, 2, and
). No significant interaction was found between gender and
BC count and between age and WBC count, suggesting
hat WBC is a similar risk factor for mortality in men and
omen and the association between WBC count and
ortality is similar at different ages. In analyses restricted to
articipants with differential WBC count (n  6,227
bservations), the association between WBC and mortality
ersisted in participants with WBC 3,500, whereas it was
o longer significant in those with WBC 6,000 to 10,000
nd WBC 10,000 after adjustment for neutrophil count
Table 4, Model 4). Independent of confounders, neutro-
hil count remained strongly associated with mortality.
The Kaplan-Meier survival curve summarizing the rela-
ionship between baseline WBC group membership and
ortality are reported in Figure 3A. Expected survival
djusted for age, race, gender, date, BMI, smoking, physical
ctivity, and major cardiovascular risk factors estimated by
roportional hazard models are depicted in Figure 3B. The
azard associated with a given WBC group membership
ompared with the reference group was approximately
onstant over the 40 years of follow-up. Above the thresh-
Count
ndent Model
del 2 Model 3 Model 4
.36–6.31) 3.33 (1.38–8.05) 1.91 (1.19–3.07)
.0 1.0 1.0
.18–1.70) 1.33 (1.10–1.60) 0.96 (0.83–1.10)
.55–3.12) 2.12 (1.45–3.08) 0.941 (0.67–1.30)
.09–1.11) 1.10 (1.09–1.11) 1.10 (1.09–1.30)
.93–0.96) 0.95 (0.93–0.96) 0.92 (0.62–0.96)
.82–1.48) 1.09 (0.79–1.50) 1.02 (0.86–1.20)
.0 1.0 1.0
.59–1.47) 0.68 (0.30–1.54) 0.92 (0.62–1.36)
.15–1.20) 0.23 (0.09–1.50) 0.40 (0.15–1.30)
.96–1.01) 0.97 (0.95–0.99)
.90–1.10) 1 (0.90–1.10)
.0 1.0
.78–1.12) 1.94 (0.78–1.14)
.11–2.18) 1.61 (1.13–2.29)
1.01 (1.00–1.02)
1.00 (1.00–1.01)
1.00 (1.00–1.01)
1.00 (1.00–1.01)
1.37 (1.10–1.70)
1.19 (1.09–1.30)odel
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May 8, 2007:1841–50 White Blood Cell Count and Mortality1% higher per each baseline additional increase of 1,000
BC/mm3.
Interestingly, WBC count increased progressively in par-
icipants who died during the follow-up starting several
ears before death, whereas WBC count remained stable
ver time in those who survived (Fig. 4A). In the subgroup
ith differential count available, the rise of WBC count was
ostly accounted for by neutrophils and was already signif-
cant 5 years before death (Fig. 4B). Lymphocytes remained
ubstantially stable over the same period (Fig. 4C).
BC and mortality across the decades. From 1958 to
002, the crude and the age-adjusted mortality rates de-
reased over time in the entire sample and in groups with
BC 3,500 to 6,000, 6,001 to 10,000, and 10.000/mm3
Table 5). Owing to the small number of participants and
eaths, the age-adjusted mortality rate could not be reliably
stimated in the extreme group with WBC 3,500/mm3
Table 5). However, within each cohort all-cause mortality
ere significantly higher in participants with WBC
6,000/mm3 than in those with WBC 3,500 to 6,000/
m3. After adjustment for age, gender, smoking, race,
MI, and systolic blood pressure, the adjusted mortality
Rs for participants with WBC 3.500, 6,001 to 10,000,
nd 10,000/mm3 compared with WBC 3,500 to 6,000/
m3 tended to decline in subsequent decades from 1960 to
000 (Table 5).
iscussion
ver the period from 1958 to 2002, we observed a down-
ard trend in WBC count and a parallel decline in
ge-specific mortality. The WBC count was nonlinearly
ssociated with all-cause mortality and almost linearly asso-
iated with cardiovascular mortality. The independent as-
ociation between WBC count and mortality was main-
ained in subsequent cohorts. Within WBC count strata
,500 to 6,000, 6,001 to 10,000, and 10,000/mm3, mor-
ality rates were progressively lower in successive cohorts
rom the 1960s to the 1990s, suggesting that the secular
owntrend in WBC count was not a major cause of the
ecline in mortality.
Our findings are the first evidence of a downward trend in
BC count over the period from 1958 to 2002. The secular
ownward trend in WBC count might be attributed to
oncurrent environmental changes (i.e., less exposure to
nfective agents and/or improved sanitary conditions) and
ifestyle modifications (i.e., smoking, physical activity, diet,
nd alcohol) (23,24). In the BLSA population, the percent-
ge of current smokers declined from 40% in the early 1960s
o 10% by the early 1990s, and this decline was 25%
reater than in the whole U.S. population. This study
onfirmed the theoretical impact of smoking on WBC
ount and previous findings that tobacco abstinence is
ssociated with lower WBC and neutrophil count (24,25).
dditionally, we found that the WBC count secular down- crend was partially independent of changes in smoking
ehavior over the same period.
Obesity is associated with a proinflammatory state (26),
Figure 4 Longitudinal Changes in WBC,
Neutrophil, and Lymphocyte Counts
Longitudinal changes of age- and date-adjusted (A) white blood cell (WBC),
(B) neutrophil, and (C) lymphocyte counts observed in the BLSA participants
according to time before death for participants who died during the follow-up,
and time before censorship for those who were censored. Note that neutro-
phils and lymphocytes are limited to participants who had differential WBC
count (n  6,227). 95% confidence interval estimated by a bootstrapping
method.haracterized by increased C-reactive protein, interleukin-6,
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White Blood Cell Count and Mortality May 8, 2007:1841–50nd WBC count (27). In the BLSA participants, an
pward secular trend in BMI occurred, particularly be-
inning in the late 1980s (28). Although BMI and WBC
ount were correlated, the secular downward trend in
BC was independent of changes in BMI.
Physical activity might also affect both the WBC down-
ard trend and the mortality via the beneficial effect of
xercise on the innate and adaptive immunity. Regular
xercise might positively impact the release of anti-
nflammatory cytokines (29,30), T-helper1/T-helper2 im-
alance and neutrophil, natural killer cell, and macrophages
ctivity (31). In the BLSA population, we found a slight
pward longitudinal trend in physical activity, particularly
rom 1970s to 1990s (15). Interestingly, most physically
ctive participants were in the lowest risk WBC count
roup, and physical activity was inversely associated with
BC count, but we found no evidence that changes in
hysical activity affected secular WBC downtrend.
We showed a nonlinear relationship between WBC
Mortality Risk in Each WBC Count Group Accorto the Baseline Ev luation Acr ss 4 Decades f
Table 5 Mortality Risk in Each WBC Countto the Baseline Evaluation Across 4
<3,500
1960–1969
Subjects (n) 2
Age, mean  SD (yrs) 69.1 10.5
Rate/1,000 persons* 86.9 (2/23)
Adjusted rate/1,000 persons† —
Hazard ratio (95% CI) 6.3 (1.56–25.8)
Adjusted hazard ratio‡ (95% CI) 3.3 (0.82–13.6)
1970–1979
Subjects (n) 4
Age, mean  SD (yrs) 64.6 11.6
Rate/1,000 persons* 42.3 (3/71)
Adjusted rate/1,000 persons† —
Hazard ratio (95% CI) 2.4 (0.79–7.38)
Adjusted hazard ratio‡ (95% CI) 2.2 (0.68–6.87)
1980–1989
Subjects (n) 11
Age, mean  SD (yrs) 55.4 22.0
Rate/1,000 persons* 10.9 (2/184)
Adjusted rate/1,000 persons† —
Hazard ratio (95% CI) 0.7 (0.18–2.89)
Adjusted hazard ratio‡ (95% CI) 0.8 (0.20–3.32)
1990–2002
Subjects (n) 42
Age, mean  SD (yrs) 56.7 14.0
Rate/1,000 persons* 9.1 (2/220)
Adjusted rate/1,000 persons† —
Hazard ratio (95% CI) 0.7 (0.18–2.88)
Adjusted hazard ratio‡ (95% CI) 0.7 (0.09–5.12)
*Crude mortality rate (number of events/1,000 persons). †Race- and g
group the adjusted mortality rate was not estimated because of the s
gender, smoking, race, body mass index, and systolic blood pressure.
CI  confidence interval; WBC  white blood cell.ount and all-cause and cancer mortality and a linear celationship between WBC count and cardiovascular mor-
ality (9). Our findings that participants with 6,000
BC/mm3 had higher mortality risk compared with those
ith WBC 3,500 to 6,000/mm3 are consistent with current
ublished data suggesting that high WBC count is a risk
actor for mortality (4–9). The significant higher mortality
isk, even within the normal range of WBC (6,000 to
0,000/mm3) compared with WBC 3,500 to 6,000/mm3,
uggest that WBC count is a marker of subclinical disease
4,10). Although we need to use caution in interpreting the
igher mortality observed in participants with WBC 3,500/
m3, because of limited sample size and small number of
vents, this finding might indicate that participants in this
BC group had general poor health status (32).
The secular mortality decline, observed in subsequent
LSA cohorts enrolled from the 1960s to the 1990s, is at
east in part independent of WBC secular downward trend
nd suggests that other factors, such as the changes in the
reatment of inflammatory related conditions, should be
w-Up
According
ades of Follow-Up
WBC Count (Groups)
01–6,000 6,001–10,000 >10,000
200 530 83
.7 15.2 53.1 14.5 52.2 14.4
114/5,697) 27.4 (368/13,438) 33.2 (65/1,957)
35.1 40.6 47.7
1 1.4 (1.14–1.73) 1.7 (1.29–2.38)
1 1.3 (1.02–1.56) 1.6 (1.26–2.36)
481 538 45
.3 16.7 53.7 16.8 49.0 17.1
209/11,228) 25.0 (289/11,542) 21.0 (83/1,001)
26.1 29.1 31.1
1 1.4 (1.14–1.63) 1.1 (0.73–1.79)
1 1.2 (1.02–1.46) 1.3 (0.80–2.04)
570 815 41
.8 18.2 57.5 18.0 54.7 20.4
151/9,932) 22.5 (305/13,546) 25.5 (17/667)
12.8 14.8 21.8
1 1.4 (1.22–1.80) 1.5 (0.98–2.43)
1 1.1 (0.91–1.36) 1.4 (0.85–2.35)
886 893 56
.5 17.3 59.6 17.1 62.1 18.1
191/7,253) 20.9 (169/8,101) 31.5 (15/476)
5.8 8.6 9.0
1 1.4 (1.10–1.81) 2.2 (1.28–3.80)
1 1.0 (0.81–1.34) 1.2 (0.66–2.15)
djusted mortality rate estimated at age 60; in the WBC3,500/mm3
mple size. ‡Cox proportional hazard model with adjustments for age,dingFollo
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May 8, 2007:1841–50 White Blood Cell Count and Mortalityound that those who died during the follow-up had a
rogressive elevation in WBC and neutrophil counts start-
ng 5 years before death, whereas those who remained alive
ad an opposite trend in both WBC and neutrophil counts.
n the same BLSA subgroup, neutrophils mainly accounted
or the effect of WBC on mortality, suggesting that a
pecific cell type or other aspects of inflammation might
ause vascular disease and be directly associated with in-
reased mortality (8,9,33,34).
The present study has limitations. The BLSA sample
ncludes highly educated individuals of high socioeconomic
tatus who were considered healthy at study entry and
herefore are not representative of the general population.
ata from women were available only from 1978, and data
rom American minorities are available only from 1990.
ethods of WBC determination changed over time. How-
ver, measurements were performed in the same clinical
aboratory, comparability between different methods were
irectly verified, and sudden changes in the WBC count
ver time ascribable to changes in methodology were not
etected. Although the major traditional cardiovascular
isk factors were considered in our analysis, we had no
nformation on inflammatory factors, high-density li-
oprotein cholesterol, coagulation factors, and so forth,
or which WBC might be a surrogate marker. Inclusion
f these factors in the analysis might have explained to a
reater extent the relationship between WBC count and
ortality.
In conclusion, our study suggests a downward trend in
BC count only partially explained by behavioral changes
hat occurred in the BLSA participants over the period from
958 to 2002. The age-specific mortality rate in each
uccessive cohort of participants declined over the 44 years
f follow-up, but we found little evidence that such a decline
n mortality was due to the secular downward trend in
BC. However, by showing that participants with WBC
6,000/mm3 experienced higher mortality compared with
hose with 3,501 to 6,000 WBC/mm3, that the increased
isk of mortality associated with high WBC was maintained
ver the entire follow-up period, and that subjects who died
ad progressively higher neutrophil count compared with
hose who survived, our study suggests that differential
BC counts should be systematically screened and factored
n the cardiovascular risk profile and ultimately considered
n clinical decisions concerning prescription of preventive
nterventions.
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